High SHBG Symptoms: Labs to Order and Next Steps

What SHBG Actually Does and Why It Matters

SHBG is a glycoprotein produced primarily by the liver. It binds sex steroids with high affinity, and its concentration directly determines how much testosterone and estradiol remain biologically active. About 60 to 70% of circulating testosterone rides on SHBG, another 30 to 40% loosely attaches to albumin, and only 1 to 3% circulates freely [1]. That small free fraction drives tissue-level effects: muscle protein synthesis, libido signaling in the hypothalamus, bone mineral maintenance, and red blood cell production.

When SHBG climbs, it pulls more hormone out of the free pool. A man with a total testosterone of 550 ng/dL and an SHBG of 90 nmol/L may have a calculated free testosterone well below the reference range. He is, for practical purposes, functionally hypogonadal. The same math applies to women: rising SHBG reduces free estradiol and free testosterone simultaneously, which can produce vaginal dryness, fatigue, and loss of sexual interest even when total estradiol reads within normal limits [3].

The clinical trap is straightforward. Clinicians who check only total testosterone or total estradiol will see "normal" values and reassure the patient. The symptoms persist. The 2018 Endocrine Society guideline on male hypogonadism explicitly warns against this, stating that "measurement of free or bioavailable testosterone is needed to establish a diagnosis" whenever SHBG is suspected to be abnormal [2].

Recognizing the Symptom Pattern

The symptom profile of high SHBG is really the symptom profile of low free hormones. Expect overlap with classical hypogonadism, perimenopause, or hypothyroidism. That overlap is exactly what makes the condition easy to miss.

In men, the most reported complaints are reduced morning erections, low libido, difficulty building or maintaining muscle, increased abdominal adiposity, fatigue that does not resolve with sleep, and a flat or irritable mood. A 2010 study of 3,219 men in the European Male Ageing Study (EMAS) found that sexual symptoms (poor morning erections, low sexual desire, erectile dysfunction) correlated most tightly with free testosterone rather than total testosterone [4]. SHBG increased by roughly 1.2% per year of age in that cohort, steadily tightening the hormonal bottleneck.

In women, high SHBG often presents as decreased libido, persistent fatigue, vaginal dryness, thinning hair, and difficulty with arousal or orgasm. These symptoms are frequently attributed to "stress" or perimenopause without anyone checking SHBG. Women on oral contraceptive pills (OCPs) are a particularly common subgroup: OCPs raise SHBG two to fourfold through the hepatic first-pass effect, and some women maintain elevated SHBG for months to years after discontinuation [5].

Short sentence for emphasis: The lab reveals what the symptoms cannot.

A practical screening question set for clinicians includes: (1) Does the patient have symptoms consistent with androgen deficiency? (2) Is total testosterone in the lower half of the reference range or "normal" but unconvincing? (3) Does the patient have a known SHBG-raising condition? If two of three are yes, measure SHBG and calculate free testosterone.

Which Labs to Order and How to Interpret Them

Start with a focused but thorough panel. Ordering SHBG in isolation is not enough because the value must be interpreted alongside total hormone levels, binding competitors, and hepatic and thyroid function.

Core panel:

• Total testosterone (morning draw for men, any time for women on stable cycles)
• SHBG (same sample)
• Albumin (needed for the Vermeulen free testosterone calculation)
• Calculated free testosterone or equilibrium dialysis free testosterone if available
• Estradiol (especially in women or men on aromatase inhibitors)

Cause-finding panel:

• TSH and free T4 to rule out hyperthyroidism, one of the most common and correctable causes of elevated SHBG [6]
• Hepatic function panel (AST, ALT, GGT, bilirubin) because hepatocellular damage or cholestatic disease upregulates SHBG synthesis
• LH and FSH to differentiate primary from secondary gonadal dysfunction
• Fasting insulin or HOMA-IR because insulin resistance inversely correlates with SHBG; a paradoxically high SHBG in an insulin-resistant patient may point toward hepatic pathology or concurrent thyroid disease [7]
• Prolactin if libido or menstrual symptoms are prominent, to exclude a prolactinoma

Reference ranges to keep in mind: Male SHBG typically runs 10, 57 nmol/L, female premenopausal SHBG 18, 114 nmol/L. But ranges vary across assays and laboratories. Context matters more than cutoffs. An SHBG of 65 nmol/L in a 25-year-old man with a total testosterone of 400 ng/dL and clear symptoms warrants investigation even though 65 nmol/L is technically "within range" in some lab reference brackets [2].

Dr. Shalender Bhasin, principal investigator of the Testosterone Trials (TTrials) and professor at Brigham and Women's Hospital, has noted: "Total testosterone can be misleading. The clinician must account for SHBG to determine whether the patient's androgen exposure at the tissue level is truly adequate" [8].

The Vermeulen calculation uses total testosterone, SHBG, and albumin to estimate free testosterone and is endorsed by the Endocrine Society as a reliable alternative when equilibrium dialysis is unavailable [2]. Free testosterone by analog immunoassay (the cheap direct assay many commercial labs offer) is unreliable and should not guide clinical decisions.

Common Causes of Elevated SHBG

Elevated SHBG is not a disease. It is a signal that something upstream is driving hepatic SHBG production higher than baseline. Identifying that driver is the clinical task.

Hyperthyroidism. Thyroid hormone directly stimulates hepatic SHBG gene transcription. A 1994 study in the Journal of Clinical Endocrinology & Metabolism demonstrated that SHBG fell by an average of 52% within 8 weeks of restoring euthyroid status in patients treated for Graves' disease [6]. This makes TSH testing non-negotiable in any workup for unexplained high SHBG.

Aging. SHBG rises roughly 1 to 2% per year after age 40 in men. The EMAS cohort confirmed this gradient across 3,369 community-dwelling men aged 40, 79, with the steepest climb occurring after age 60 [4]. Women also see SHBG increases after menopause, though the clinical effect is often overshadowed by falling total estradiol.

Oral estrogen. Both oral contraceptive pills and oral menopausal hormone therapy (HT) increase SHBG through first-pass hepatic metabolism. Transdermal estradiol largely avoids this effect. A randomized crossover trial published in Menopause found that switching from oral conjugated equine estrogen to transdermal 17-beta estradiol reduced SHBG by 41% while maintaining symptom relief [9]. The 2022 Menopause Society position statement recommends transdermal delivery in women who are concerned about thromboembolic risk or who demonstrate symptomatic SHBG elevation on oral therapy [10].

Liver disease. Hepatitis, cirrhosis, and non-alcoholic fatty liver disease in its later fibrotic stages can all raise SHBG, though the mechanism differs from the insulin-mediated SHBG suppression seen in early metabolic syndrome. When you see high SHBG plus abnormal liver enzymes, imaging and a hepatology referral are appropriate before adjusting hormones [7].

Caloric restriction and low body weight. Chronic energy deficit raises SHBG, likely as a reproductive-axis downregulation signal. This pattern appears frequently in endurance athletes, patients with eating disorders, and individuals on very-low-calorie diets. Refeeding and achieving a sustainable caloric surplus can reduce SHBG without any pharmacologic intervention [11].

Anticonvulsants. Phenytoin, carbamazepine, and valproate increase SHBG through hepatic enzyme induction. Switching to a non-enzyme-inducing anticonvulsant (levetiracetam, lamotrigine) often normalizes SHBG over 3 to 6 months [12].

HIV infection. Chronic HIV, even with viral suppression, is associated with SHBG levels 20 to 40% higher than age-matched controls, contributing to the high prevalence of functional hypogonadism in men living with HIV [13].

Treatment: Addressing the Root Cause First

There is no FDA-approved drug whose indication is "lower SHBG." Treatment means correcting whatever is pushing SHBG up, then reassessing free hormone levels and symptoms.

Correct thyroid dysfunction. If TSH is suppressed and free T4 or T3 is elevated, treating the hyperthyroidism will bring SHBG down within weeks. A repeat SHBG 6 to 8 weeks after achieving euthyroid status confirms the connection [6].

Switch oral estrogen to transdermal. For women on OCPs or oral HT who develop high-SHBG symptoms, transitioning to a transdermal patch, gel, or ring eliminates the hepatic first-pass spike. The 2022 North American Menopause Society position statement supports transdermal estradiol as a preferred route for women with elevated SHBG, VTE risk factors, or hypertriglyceridemia [10].

Optimize body composition and nutrition. In patients with low BMI or chronic caloric restriction, a targeted increase in caloric intake (particularly dietary fat and protein) can lower SHBG. Resistance training has also been associated with modest SHBG reductions in observational data, likely mediated through improved insulin sensitivity and increased lean mass [14].

Re-evaluate anticonvulsants. When a patient on phenytoin or carbamazepine develops androgen-deficiency symptoms and labs confirm high SHBG with low free testosterone, a neurology consultation to discuss switching to a non-enzyme-inducing agent is reasonable.

Consider testosterone therapy when the cause is not correctable. In men with persistently elevated SHBG where the underlying cause cannot be reversed (aging, stable liver disease, idiopathic), and who meet diagnostic criteria for hypogonadism based on low calculated free testosterone plus symptoms, testosterone replacement therapy is appropriate per the 2018 Endocrine Society guideline [2]. The guideline states: "We recommend testosterone therapy for men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density." The threshold for treatment is a confirmed free testosterone below the lower limit of normal for young healthy men, not a specific SHBG cutoff.

Boron supplementation has generated patient-community interest. A small 2011 study (N=13) found that 6 mg of boron daily for one week reduced SHBG by approximately 9% in healthy men [15]. The sample size and duration limit clinical conclusions, but the safety profile of boron at this dose is favorable, and some clinicians include it as an adjunctive measure while addressing the primary cause.

Nettle root extract (Urtica dioica) is often marketed as an SHBG-lowering supplement. In vitro studies have demonstrated binding competition with SHBG, but no controlled clinical trial has confirmed a meaningful reduction in SHBG or improvement in free testosterone in humans [16]. Patients should be counseled that the evidence base does not support using nettle root as a standalone treatment.

Monitoring After Intervention

Once the suspected driver has been addressed, recheck labs at 6 to 8 weeks with the same core panel: total testosterone, SHBG, albumin, and calculated free testosterone. If symptoms have resolved and free testosterone has normalized, the working diagnosis was correct.

If SHBG remains elevated despite correcting all identifiable causes, consider a referral to endocrinology for further evaluation. Rare genetic variants in the SHBG gene (rs6258, rs6259) can produce constitutively high SHBG that does not respond to lifestyle or pharmacologic intervention [17]. In these patients, the management question shifts to whether testosterone therapy is indicated to overcome the binding excess.

Track symptoms with a standardized instrument. The Androgen Deficiency in the Aging Male (ADAM) questionnaire or the Aging Males' Symptoms (AMS) scale can be repeated at each follow-up to document clinical improvement alongside lab normalization [4].

A reasonable re-evaluation schedule: labs at baseline, 6 to 8 weeks post-intervention, 3 months, and then every 6 to 12 months if the patient is on testosterone replacement or ongoing hormonal therapy. Men on TRT require additional monitoring of hematocrit, PSA, and lipid profile per the Endocrine Society protocol [2].

When to Refer to a Specialist

Most cases of elevated SHBG can be managed by a primary care physician or telehealth clinician who is comfortable interpreting free testosterone calculations and ordering a cause-finding panel. Referral to endocrinology is indicated when:

• SHBG remains elevated after correcting all identifiable causes
• The patient has concurrent pituitary pathology (elevated prolactin, abnormal LH/FSH pattern)
• Liver imaging reveals fibrosis, cirrhosis, or a hepatic mass
• The patient is a premenopausal woman with persistent symptoms after OCP discontinuation and SHBG normalization has not occurred within 6 to 12 months

Hepatology referral is appropriate when liver enzymes are persistently abnormal and the clinician suspects hepatic synthesis derangement as the primary SHBG driver [7].

Patients with suspected eating disorders or relative energy deficiency in sport (RED-S) benefit from co-management with a dietitian and, where appropriate, a mental health professional. The hormonal disruption in these cases will not resolve until the energy deficit is corrected [11].

The bottom line: an SHBG level is never the diagnosis. It is the first clue. The diagnosis is whatever is driving it up, and the treatment is removing or mitigating that driver. If the driver cannot be removed, hormone replacement targeted at raising free testosterone or free estradiol into the symptomatic-relief range is the fallback, guided by repeat labs every 6 to 8 weeks until stable.